We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fast, Cheap, and Easy Testing Method Could Become a Game-Changer in Antibiotic Sensitivity Testing

By LabMedica International staff writers
Posted on 26 Apr 2023

Antibiotic resistance, which has become a critical global public health issue, occurs when bacteria evolve to withstand the drugs designed to eliminate them. More...

Antibiotic sensitivity testing (AST) typically involves culture or genetic methods to determine bacterial resistance. Conventional ASTs can take up to 24 hours or longer for slow-growing bacteria, a critical period in clinical settings. Although faster ASTs have been developed, they often require complex and costly equipment. Researchers have now created a rapid, affordable, and accessible method based on optical microscopy that can perform AST at the single-cell level without needing to attach or label bacteria. The technique utilizes a standard optical microscope, a camera or mobile phone, and specialized software.

The new technique developed by researchers at EPFL (Lausanne, Switzerland) and Vrije Universiteit Brussel (Brussels, Belgium) is called optical nanomotion detection (ONMD) and monitors the nanoscale vibrations of individual bacteria before and during antibiotic exposure. Monitoring is performed using a basic optical microscope and a video camera or mobile phone. ONMD observes the microscopic oscillations (nanomotion) of bacterial cells, which signify living organisms and serve as a "signature of life." Nanomotion persists as long as the organism is alive, ceasing immediately upon death. In ONMD, bacterial nanomotion is captured in a video where individual cell movements are monitored with sub-pixel resolution.

Researchers successfully applied ONMD to detect the sensitivity of various bacteria to antibiotics, determining the sensitivities of Escherichia coli, Staphylococcus aureus, Lactobacillus rhamnosus, and Mycobacterium smegmatis (a non-pathogenic bacterial model for tuberculosis) sensitivities to antibiotics like ampicillin, streptomycin, doxycycline, and vancomycin in under two hours. ONMD not only tracks bacteria's life-death transitions upon antibiotic exposure but also reveals changes in bacterial metabolism due to nutrient availability. Tests demonstrated that ONMD can quickly and simply evaluate bacterial sensitivity or resistance to antibiotics by monitoring cellular oscillations. The researchers believe that the method's simplicity and effectiveness make it a game-changer in AST, with far-reaching implications for clinical and research applications, as it can be applied to a wide variety of bacteria.

“We have developed a technique in our laboratories that allows us to obtain an antibiogram within 2-4 hours – instead of the current 24 hours for the most common germs and one month for tuberculosis,” said Dr. Sandor Kasas at EPFL.

“Our technique is not only faster but also simpler and much cheaper than all those existing now,” added Professor Ronnie Willaert at Vrije Universiteit Brussel.

Related links:
EPFL
Vrije Universiteit Brussel


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers compared Huntington’s disease biomarkers in CSF and blood with clinical assessments and brain imaging to better understand changes before clinical onset (Image Credit: Adobe Stock)

Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease

Huntington’s disease is a genetic disorder caused by a mutation in the HTT gene that progressively affects movement, cognition, behavior, and independence. Although mutation carriers can be identified... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.